Accelerating drug development through collaboration

Insights into academic-pharma partnerships

Research institutions have long sought partnerships with the pharmaceutical industry to advance their research and secure new funding streams. Understanding the historical landscape of research institution and pharma partnerships can help you make decisions about the best financial and structural deals for your institution. In this report, we use data from Cortellis Competitive Intelligence™ and Cortellis Deals Intelligence™ to provide insights on:

  • patenting hotspots in the academic drug research landscape,
  • partnering activity in institutions worldwide,
  • influences that might be driving any differences in partnering activity,
  • the clinical phase timing of deal making between research institutions and pharmaceutical companies and
  • best practice approaches for aligning academic research with pharmaceutical industry needs to achieve the maximum impact.

Fill out the form at the right to get your copy now!